IoM Immunization Safety Committee Will Review Possible MMR/Autism Link
A potential link between measles-mumps-rubella vaccine and autism will be the first safety concern facing the Institute of Medicine Immunization Safety Review Committee.
You may also be interested in...
Rep. Burton's vaccine safety investigation will expand to include subpoenas to manufacturers regarding potential conflicts of interest associated with advisory committee review of vaccines.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials